Results 61 to 70 of about 102,878 (208)

Impact of IgG monitoring and machine learning based prediction on outcomes of ABO incompatible kidney transplantation in blood type O recipients

open access: yesScientific Reports
ABO-incompatible kidney transplantation (ABO-i KT) facilitates transplantation across blood types; however, antibody-mediated rejection (ABMR) remains a major concern, particularly in blood type O recipients. This retrospective study evaluated the effect
Youngmin Ko   +8 more
doaj   +1 more source

Bowel complications requiring surgical intervention in kidney transplant recipients: a retrospective study of clinical characteristics and risk factors

open access: yesClinical Transplantation and Research
Background : Bowel complications following kidney transplantation (KT) are rare but life-threatening, often necessitating bowel resection. These complications are associated with immunosuppressive therapy, comorbidities, and viral infections.
Jin-Myung Kim   +7 more
doaj   +1 more source

Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants [PDF]

open access: yes, 1995
The presence of hepatitis B virus (HBV) DNA in extrahepatic tissues has been well documented. Whether HBV DNA can persist in extrahepatic tissues for long periods of time in the absence of replication in the liver has not been determined previously ...
Davidson   +19 more
core   +1 more source

Isolated Pancreatic Transplantation in a Brazilian Centre

open access: yesBrazilian Journal of Transplantation, 2008
Purpose. Simultaneous pancreas-kidney transplantation (SPK) is an accepted treatment for patients with type 1 diabetes mellitus and end- stage renal disease. Modern immunosuppression and biopsy techniques have improved the success of pancreas alone (PA)
João Eduardo Nicoluzzi   +3 more
doaj   +1 more source

Pancreas transplantation

open access: yesNephrology Dialysis Transplantation, 2020
Andrew, Sutherland, Lorna, Marson
openaire   +3 more sources

Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis

open access: yesCurrent Internal Medicine Research and Practice Surabaya Journal
Introduction: Refractory ascites is a frequent complication associated with liver cirrhosis. Tolvaptan, a V2-receptor antagonist, has shown effectiveness in improving refractory ascites.
Chetan Kalal   +3 more
doaj   +1 more source

Pancreas transplantation: review

open access: yesCirugía y Cirujanos (English Edition)
Pancreas transplant (PTx) is the only treatment that establishes normal glucose levels for patients diagnosed with diabetes types 1 and 2. The paper aims to review and analyze graft survival, patient survival, and the impact on diabetic complications. We describe that the graft survival was 82-98% at 1 year, 90% at 5 years, and 75-54% at 10 years for ...
Pamela S, Espinoza-Loyola   +12 more
openaire   +2 more sources

Treatment options for PNET liver metastases. a systematic review [PDF]

open access: yes, 2018
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor.
Aurello, Paolo   +8 more
core   +1 more source

Outcomes and risk score for distal pancreatectomy with celiac axis resection (DP-CAR) : an international multicenter analysis [PDF]

open access: yes, 2019
Background: Distal pancreatectomy with celiac axis resection (DP-CAR) is a treatment option for selected patients with pancreatic cancer involving the celiac axis.
Adham, Mustapha   +50 more
core   +2 more sources

Perfusion Techniques in Kidney Allograft Preservation to Reduce Ischemic Reperfusion Injury: A Systematic Review and Meta-Analysis

open access: yesAntioxidants
The limited supply and rising demand for kidney transplantation has led to the use of allografts more susceptible to ischemic reperfusion injury (IRI) and oxidative stress to expand the donor pool.
Bima J. Hasjim   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy